title: Inhibition of iridovirus protein synthesis and virus replication by antisense morpholino oligonucleotides targeted to the major capsid protein, the 18 kDa immediate-early protein, and a viral homolog of RNA polymerase II.
abstract: Frog virus 3 (FV3) is a large DNA virus that encodes approximately 100 proteins. Although the general features of FV3 replication are known, the specific roles that most viral proteins play in the virus life cycle have not yet been elucidated. To address the question of viral gene function, antisense morpholino oligonucleotides (asMOs) were used to transiently knock-down expression of specific viral genes and thus infer their role in virus replication. We designed asMOs directed against the major capsid protein (MCP), an 18 kDa immediate-early protein (18K) that was thought to be a viral regulatory protein, and the viral homologue of the largest subunit of RNA polymerase II (vPol-IIalpha). All three asMOs successfully inhibited translation of the targeted protein, and two of the three asMOs resulted in marked phenotypic changes. Knock-down of the MCP resulted in a marked reduction in viral titer without a corresponding drop in the synthesis of other late viral proteins. Transmission electron microscopy (TEM) showed that in cells treated with the anti-MCP MO assembly sites were devoid of viral particles and contained numerous aberrant structures. In contrast, inhibition of 18K synthesis did not block virion formation, suggesting that the 18K protein was not essential for replication of FV3 in fathead minnow (FHM) cells. Finally, consistent with the view that late viral gene expression is catalyzed by a virus-encoded or virus-modified Pol-II-like protein, knock-down of vPol-IIalpha triggered a global decline in late gene expression and virus yields without affecting the synthesis of early viral genes. Collectively, these results demonstrate the utility of using asMOs to elucidate the function of FV3 proteins.
authors.affiliation: Department of Microbiology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Sample
authors.forename: Locke
authors.initials: L
authors.lastname: Bryan
authors.forename: Scott
authors.initials: S
authors.lastname: Long
authors.forename: Sai
authors.initials: S
authors.lastname: Majji
authors.forename: Glenn
authors.initials: G
authors.lastname: Hoskins
authors.forename: Allan
authors.initials: A
authors.lastname: Sinning
authors.forename: Jake
authors.initials: J
authors.lastname: Olivier
authors.forename: V Gregory
authors.initials: VG
authors.lastname: Chinchar
mesh_terms: D036022:Capsid Proteins / Q000096:biosynthesis*; D002460:Cell Line; D004266:DNA Virus Infections / Q000821:virology; D005818:Genetic Engineering / Q000379:methods; D006801:Humans; D008970:Molecular Weight; D016376:Oligonucleotides, Antisense; D012319:RNA Polymerase II / Q000096:biosynthesis*; D017995:Ranavirus / Q000187:drug effects / Q000502:physiology*; D014764:Viral Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000502:physiology*; D014779:Virus Replication
chemical_list: D036022:Capsid Proteins; D016376:Oligonucleotides, Antisense; D014764:Viral Proteins; D012319:RNA Polymerase II